Utility Menu

National Association of Pharmacy Regulatory Authorities

Provinces

Main navigation


Search: National Drug Schedules

Begin your search by using the generic name of the product:

Search by Glossary
Drug Name Comment Schedule Date
Tolazoline or its saltsPDL I DEC / 13
TolbutamidePDL I DEC / 13
TolcaponePDL I DEC / 13
Tolfenamic acid or its salts or derivativesPDL I DEC / 13
Tolmetin or its saltsPDL I DEC / 13
Tolterodine or its saltsPDL I DEC / 13
Toltrazuril or its salts or derivativesPDL

Including but not limited to Ponazuril 

I DEC / 13
Tolvaptan or its derivativesPDL I DEC / 13
TopiramatePDL I DEC / 13
Topotecan or its saltsPDL I DEC / 13
Torasemide or its saltsPDL I DEC / 13
Toremifene or its saltsPDL I DEC / 13
Trabectedin or its salts or derivativesPDL I DEC / 13
Tramadol or its saltsPDL I DEC / 13
Trametinib or its salts or derivativesPDL

Including but not limited to Trametinib dimethylsulfoxide.

I DEC / 13
Trandolapril or its salts or derivativesPDL I DEC / 13
Tranexamic acidPDL I DEC / 13
TranylcyprominePDL I DEC / 13
TrastuzumabPDL I DEC / 13
Trastuzumab emtansinePDL I DEC / 13
Trazodone or its saltsPDL I DEC / 13
TrenboloneC3 I JUN / 02
TreosulfanPDL I DEC / 13
TretaminePDL I DEC / 13
Tretinoin or its salts or derivativesPDL I DEC / 13
Triamcinolone acetonide

in an aqueous nasal spray that delivers 55 mcg per metered spray for adults and children 12 years of age and older, in package sizes containing more than 120 metered sprays

II JAN / 15
Triamcinolone acetonide.

in an aqueous nasal spray that delivers 55 mcg per metered spray for adults and children 12 years of age and older, in package sizes containing no more than 120 metered sprays

III JAN / 15
Triamterene or its saltsPDL I DEC / 13
Triazolam and its saltsTS I SEP / 98
Tricaine or its saltsPDL I DEC / 13
Triethanolamine oleate III SEP / 98
Triethanolamine salicylate in concentrations greater than 20% III SEP / 98
Triethanolamine salicylate. in concentrations up to and including 20% U
Trifarotene or its saltsPDL I FEB / 20
Trifluoperazine or its saltsPDL I DEC / 13
Triflupromazine or its saltsPDL I DEC / 13
TrifluridinePDL I DEC / 13
Trihexyphenidyl or its saltsPDL I DEC / 13
Triiodothyropropionic acidPDL I DEC / 13
TrilostanePDL I DEC / 13
Trimebutine or its saltsPDL I DEC / 13
TrimeperidineN I JUN / 02
Trimeprazine or its saltsPDL

For human use.

I DEC / 13
TrimethadionePDL I DEC / 13
Trimethaphan camsylatePDL I DEC / 13
Trimethoprim or its saltsPDL I DEC / 13
Trimetrexate or its saltsPDL I DEC / 13
Trimipramine or its saltsPDL I DEC / 13
TrioxsalenPDL I DEC / 13
Tripelennamine and its salts III SEP / 98
Triprolidine III SEP / 98
Triptorelin or its salts or derivativesPDL I DEC / 13
TroglitazonePDL I DEC / 13
Tropicamide or its saltsPDL

For human use - in preparations for parenteral or ophthalmic use, except when sold for use in diagnostic procedures to an optometrist registered in a province of Canada.

I DEC / 13
Tropicamide or its saltsPDL

For veterinary use.

I DEC / 13
Trospium chloridePDL I DEC / 13
Trovafloxacin or its salts or derivativesPDL

including but not limited to alatrofloxacin

I DEC / 13
Tubocurarine chloridePDL I DEC / 13
Tucatinib or its salts or derivativesPDL I JUL / 20
TulathromycinPDL

For veterinary use.

I DEC / 13
TybamatePDL I DEC / 13
Tylosin or its salts or derivativesPDL

Including but not limited to: Tildipirosin, tilmicosin, tylvalosin.

I DEC / 18
Typhoid vaccines/Salmonella Typhi vaccines I FEB / 02
Tyrothricine III SEP / 98

164 result(s)


Footnotes

  • C1: Drug is in the Controlled Drugs and Substances Act and Part I of the Schedule to Part G of the Food and Drug Regulations
  • C2: Drug is in the Controlled Drugs and Substances Act and Part II of the Schedule to Part G of the Food and Drug Regulations
  • C3: Drug is in the Controlled Drugs and Substances Act and Part III of the Schedule to Part G of the Food and Drug Regulations
  • C4: drug is in the Controlled Drugs and Substances Act
  • C5: drug is in the Regulations Under CDSA
  • CR: drug has been recommended for addition to the Controlled Drugs and Substances Act
  • CR-C: drug has been recommended for addition to the Controlled Drugs and Substances Act, Part G of the Food and Drug Regulations
  • CR-N: drug has been recommend for addition to the Controlled Drugs and Substances Act, Narcotic Control Regulations
  • CR-TS: drug has been recommended for addition to the Controlled Drugs and Substances Act, Benzodiazepines and Other Targeted Substances Regulations
  • F1: drug appears in Part I of Schedule F to the Food and Drugs Act and Regulations
  • F2: drug appears in Part II of Schedule F to the Food and Drugs Act and Regulations
  • FR: drug has been recommended for addition to Schedule F to the Food and Drugs Act and Regulations ("Schedule F Recommended")
  • N: drug is in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
  • NR: drug has not been reviewed by NDSAC
  • PDL: drug is in the Prescription Drug List (effective Dec. 19, 2013)
  • R: drug is in Part J of the Food and Drugs Act and listed in the Controlled Drugs and Substances Act
  • TS: drug is in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
  • U: drug has been reviewed by NDSAC and is unscheduled